## **Core Concept**
The question tests knowledge of selective α1-adrenergic blockers, which are a class of drugs that inhibit the action of norepinephrine at α1-adrenergic receptors. These receptors are primarily involved in smooth muscle contraction, particularly in blood vessels, leading to vasoconstriction. Selective α1 blockers are used to treat hypertension and prostatic hyperplasia.

## **Why the Correct Answer is Right**
Prazosin is a selective α1-adrenergic receptor antagonist. It works by blocking the α1 receptors in smooth muscle, causing vasodilation and subsequently lowering blood pressure. This mechanism makes it useful in the treatment of hypertension and symptoms of benign prostatic hyperplasia. Prazosin's selectivity for α1 receptors over other adrenergic receptors (like α2 and β) makes it a valuable therapeutic agent with specific effects and relatively fewer side effects compared to non-selective blockers.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is not identified but based on the context, if it's not Prazosin, it would be incorrect because it does not match the profile of a selective α1 blocker.
- **Option B:** similarly, without the specific name, if it's not Prazosin, it doesn't fit the description of a selective α1-adrenergic blocker.
- **Option C:** Again, lacking specificity, if not Prazosin, it would not be correct.
- **Option D:** If this option is not Prazosin, then it is incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Prazosin can cause a "first-dose effect," a significant and rapid decrease in blood pressure upon the first dose, which can lead to dizziness or fainting. This effect necessitates the initiation of therapy at a low dose.

## **Correct Answer:** .